semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42624784
Not Just for Diabetes: The Next Frontier for GLP-1 Agonists.
Not Just for Diabetes: The Next Frontier for GLP-1 Agonists.
- 저자
- Henry Colangelo, Ariana Nestler, Corey Lyon
- 저널
- Journal of the American Board of Family Medicine : JABFM
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.3122/jabfm.2025.250473R1
문헌 요약
A commonly used GLP-1 agonist, semaglutide, reduces the risk of adverse cardiovascular outcomes in non-diabetic individuals with obesity and pre-existing cardiovascular disease.
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.